-
Galectin-1, FIP200, and Autophagy in Hepatic Steatosis
2026-08-18
A 2026 study identifies galectin-1 as an upstream suppressor of hepatic autophagy that promotes steatosis and insulin resistance through direct interaction with the FIP200 autophagy scaffold. Its Gal-1–FIP200 mechanism links a specific protein interface to impaired ULK-complex function, providing a mechanistic framework for studying metabolic liver disease while highlighting important limits for translation beyond the tested models.
-
Taxus chinensis Fruit, TLR4, and Neuroinflammation
2026-08-18
The reference study shows that Taxus chinensis fruit extract attenuates aging-related behavioral changes and neuroinflammation in a D-galactose mouse model by suppressing microglial activation and the TLR4/NF-κB/NLRP3 axis. Its integrated behavioral, biochemical, cellular, chemical-profiling, and docking strategy provides a useful framework for interpreting plant-derived TLR4 modulation while highlighting the need for direct target-validation studies.
-
ELP4, ZEB2, and TCF7L2 in Ischemic Stroke
2026-08-17
The reference study identifies TCF7L2 as a driver of pro-inflammatory microglial polarization after ischemic stroke and defines opposing upstream control by ELP4 and ZEB2. Its combination of ischemia models, chromatin and ubiquitination analyses, and pharmacological TLR4 inhibition provides a mechanistic framework for studying inflammatory signal pathway suppression in stroke-related neuroinflammation research.
-
β-Amanitin: From Pol II Probe to Assay Design
2026-08-17
β-Amanitin is more than a transcription inhibitor: it is a controlled perturbation tool for linking RNA polymerase II activity to assay readouts. This guide connects mechanistic experiment design with emerging amatoxin biosensing while clarifying practical handling and interpretation limits.
-
SB525334 in TGF-beta1 Receptor Signaling
2026-08-16
SB525334 provides a selective way to test whether ALK5 signaling drives profibrotic, renal, or wound-repair phenotypes. This workflow connects precise Smad2/3 readouts with the bone-transport diabetic foot ulcer findings while clearly separating validated evidence from proposed assay extensions.
-
MAPK10–KRT16 Signaling Restrains NSCLC Metastasis
2026-08-15
The reference study identifies a phosphorylation-dependent MAPK10–KRT16–RNF213 pathway that limits non-small cell lung cancer metastasis. Its combination of mechanistic, in vivo, and clinical evidence suggests that KRT16 turnover may be more informative than KRT16 transcription alone when evaluating metastatic risk.
-
Cycloastragenol Protects Against GIONFH Bone Loss
2026-08-14
This in vivo study identifies osteoclast overactivity as a modifiable component of glucocorticoid-induced osteonecrosis of the femoral head and shows that cycloastragenol preserves femoral-head structure in methylprednisolone-treated rats. Micro-CT, angiography, histology, gene-expression analysis, and protein assays together support cycloastragenol as a candidate hip-preservation strategy, while its clinical value remains to be established.
-
(5Z)-7-Oxozeaenol: A TAK1 Assay Strategy
2026-08-14
(5Z)-7-Oxozeaenol is a selective TAK1 inhibitor for dissecting inflammatory signaling and metabolic-stress adaptation. This article translates AMPK–SQSTM1 feedback-loop findings into a practical, causally resolved assay strategy.
-
Ac-YVAD-CMK: A Precision Lens on Liver Inflammation
2026-08-13
TMEM16F-dependent membrane repair in Kupffer cells reveals why inflammatory cell death must be interpreted in context. This thought-leadership guide positions Ac-YVAD-CMK as a mechanistically focused probe for separating caspase-1-driven cytokine maturation and pyroptosis from membrane injury during liver infection research.
-
MCC950 sodium: Practical NLRP3 Assay Workflows
2026-08-13
MCC950 sodium provides a selective way to test whether NLRP3 drives oxidative-stress pyroptosis rather than relying on pleiotropic anti-inflammatory compounds alone. This guide translates endothelial-cell findings into reproducible macrophage, PBMC, and disease-model workflows with practical controls and troubleshooting.
-
MCC950 sodium in Endotoxemia Workflows
2026-08-12
MCC950 sodium enables selective testing of NLRP3 contributions to cytokine release, extracellular-vesicle tissue factor, and coagulation during endotoxemia. This workflow-centered guide shows how to pair pharmacological inhibition with time-resolved inflammatory and hemostatic readouts while avoiding common interpretation errors.
-
BIBR 1532 Workflows for Telomerase Research
2026-08-12
BIBR 1532 enables direct, non-nucleosidic telomerase inhibition studies alongside proliferation, transcriptional, and apoptosis readouts. This workflow distinguishes hTERT-dependent effects from the DNA-damage and telomere-attrition mechanisms reported for CF10 plus EdU combinations.
-
Indazole Glucagon Receptor Antagonists: Study Insights
2026-08-11
This 2015 Bioorganic & Medicinal Chemistry Letters study describes indazole- and indole-based glucagon receptor antagonists derived from the earlier MK-0893 program. Its structure–activity relationship work identified compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in glucagon receptor humanized mouse models.
-
Ibrexafungerp: Antifungal Research Workflows
2026-08-11
Ibrexafungerp, also known as MK 3118, supports research on resistant Candida through a non-competitive glucan synthase mechanism and oral dosing potential. This guide connects broth microdilution, acidic-pH testing, and delayed-treatment animal models with practical optimization and troubleshooting steps.
-
Methylprednisolone in Reliable Cell Assays
2026-08-10
This scenario-based guide shows how Methylprednisolone, SKU A4233, can be incorporated into cell viability, proliferation, cytotoxicity, and inflammatory-response workflows without confusing metabolic effects with cell loss. It connects product handling data with translational glucocorticoid research and practical controls for more interpretable experiments.